Related Experiment Videos
Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities
1Department of Growth and Development, University of California, San Francisco 94143.
Abstract:
Transforming growth factor-beta (TGF-beta) is a multifunctional protein that regulates cell proliferation and differentiation and extracellular matrix production. Although two receptor types, the type I and type II receptors, have been implicated in TGF-beta-induced signaling, it is unclear how the many activities of TGF-beta are mediated through these receptors. With the use of cells overexpressing truncated type II receptors as dominant negative mutants to selectively block type II receptor signaling, the existence of two receptor pathways was shown. The type II receptors, possibly in conjunction with type I receptors, mediate the induction of growth inhibition and hypophosphorylation of the retinoblastoma gene product pRB. The type I receptors are responsible for effects on extracellular matrix, such as the induction of fibronectin and plasminogen activator inhibitor I, and for increased JunB expression. Selective inactivation of the type II receptors alters the TGF-beta response in a similar manner to the functional inactivation of pRB, suggesting a role for pRB in the type II, but not the type I, receptor pathway.
Insights
Transforming growth factor-beta (TGF-beta) utilizes two distinct receptor pathways. The type II receptor pathway mediates growth inhibition and retinoblastoma protein (pRB) hypophosphorylation, while type I receptors regulate extracellular matrix production.
Area of Science:
- Cell biology
- Molecular signaling
- Biochemistry
Background:
- Transforming growth factor-beta (TGF-beta) is a key regulator of cellular processes, including proliferation, differentiation, and extracellular matrix production.
- TGF-beta signaling is mediated by type I and type II receptors, but the distinct roles of these receptors in mediating TGF-beta's diverse functions remain unclear.
Purpose of the Study:
- To elucidate the specific roles of type I and type II receptors in mediating TGF-beta signaling pathways.
- To investigate the involvement of the retinoblastoma gene product (pRB) in TGF-beta receptor-mediated cellular responses.
Main Methods:
- Utilized cells overexpressing truncated type II receptors as dominant-negative mutants to selectively block type II receptor signaling.
- Analyzed TGF-beta-induced effects on cell proliferation, retinoblastoma gene product (pRB) phosphorylation, extracellular matrix component expression (fibronectin, plasminogen activator inhibitor I), and JunB expression.
Main Results:
- Demonstrated the existence of two distinct TGF-beta receptor pathways.
- Type II receptors, potentially with type I receptors, mediate growth inhibition and pRB hypophosphorylation.
- Type I receptors are responsible for extracellular matrix induction and increased JunB expression.
- Selective inactivation of type II receptors mimicked the effects of pRB inactivation, suggesting pRB's role in the type II pathway.
Conclusions:
- TGF-beta employs distinct type I and type II receptor pathways to regulate different cellular functions.
- The type II receptor pathway is implicated in growth control via pRB, while the type I receptor pathway influences extracellular matrix production and gene expression.